BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 20107230)

  • 21. Renal angiomyolipoma (AML) harboring a missense mutation of
    Idogawa M; Hida T; Tanaka T; Ohira N; Tange S; Sasaki Y; Uhara H; Masumori N; Tokino T; Natori H
    Cancer Biol Ther; 2020 Apr; 21(4):315-319. PubMed ID: 31847710
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Whole genome scanning as a cytogenetic tool in hematologic malignancies.
    Maciejewski JP; Mufti GJ
    Blood; 2008 Aug; 112(4):965-74. PubMed ID: 18505780
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of genome-wide copy number variants in myeloid malignancies using next-generation sequencing.
    Shen W; Paxton CN; Szankasi P; Longhurst M; Schumacher JA; Frizzell KA; Sorrells SM; Clayton AL; Jattani RP; Patel JL; Toydemir R; Kelley TW; Xu X
    J Clin Pathol; 2018 Apr; 71(4):372-378. PubMed ID: 29197855
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary mediastinal large B-cell lymphoma is characterized by large-scale copy-neutral loss of heterozygosity.
    Tuveri S; Debackere K; Marcelis L; Dierckxsens N; Demeulemeester J; Dimitriadou E; Dierickx D; Lefesvre P; Deraedt K; Graux C; Michaux L; Cools J; Tousseyn T; Vermeesch JR; Wlodarska I
    Genes Chromosomes Cancer; 2022 Oct; 61(10):603-615. PubMed ID: 35611992
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Application of array-based whole genome scanning technologies as a cytogenetic tool in haematological malignancies.
    Maciejewski JP; Tiu RV; O'Keefe C
    Br J Haematol; 2009 Sep; 146(5):479-88. PubMed ID: 19563474
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genomewide scan for loss of heterozygosity and chromosomal amplification in breast carcinoma using single-nucleotide polymorphism arrays.
    Argos M; Kibriya MG; Jasmine F; Olopade OI; Su T; Hibshoosh H; Ahsan H
    Cancer Genet Cytogenet; 2008 Apr; 182(2):69-74. PubMed ID: 18406867
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The advantage of using SNP array in clinical testing for hematological malignancies--a comparative study of three genetic testing methods.
    Xu X; Johnson EB; Leverton L; Arthur A; Watson Q; Chang FL; Raca G; Laffin JJ
    Cancer Genet; 2013; 206(9-10):317-26. PubMed ID: 24269304
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monogenic and polygenic inheritance become instruments for clonal selection.
    Loh PR; Genovese G; McCarroll SA
    Nature; 2020 Aug; 584(7819):136-141. PubMed ID: 32581363
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An integrated Bayesian analysis of LOH and copy number data.
    Rancoita PM; Hutter M; Bertoni F; Kwee I
    BMC Bioinformatics; 2010 Jun; 11():321. PubMed ID: 20550648
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Loss of heterozygosity 4q24 and TET2 mutations associated with myelodysplastic/myeloproliferative neoplasms.
    Jankowska AM; Szpurka H; Tiu RV; Makishima H; Afable M; Huh J; O'Keefe CL; Ganetzky R; McDevitt MA; Maciejewski JP
    Blood; 2009 Jun; 113(25):6403-10. PubMed ID: 19372255
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Frequent loss of heterozygosity without loss of genetic material in acute myeloid leukemia with a normal karyotype.
    Gorletta TA; Gasparini P; D'Elios MM; Trubia M; Pelicci PG; Di Fiore PP
    Genes Chromosomes Cancer; 2005 Nov; 44(3):334-7. PubMed ID: 16015648
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Copy-neutral loss of heterozygosity at the p53 locus in carcinogenesis of esophageal squamous cell carcinomas associated with p53 mutations.
    Saeki H; Kitao H; Yoshinaga K; Nakanoko T; Kubo N; Kakeji Y; Morita M; Maehara Y
    Clin Cancer Res; 2011 Apr; 17(7):1731-40. PubMed ID: 21325068
    [TBL] [Abstract][Full Text] [Related]  

  • 33. aCNViewer: Comprehensive genome-wide visualization of absolute copy number and copy neutral variations.
    Renault V; Tost J; Pichon F; Wang-Renault SF; Letouzé E; Imbeaud S; Zucman-Rossi J; Deleuze JF; How-Kit A
    PLoS One; 2017; 12(12):e0189334. PubMed ID: 29261730
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Losing balance: Hardy-Weinberg disequilibrium as a marker for recurrent loss-of-heterozygosity in cancer.
    Wilkins K; LaFramboise T
    Hum Mol Genet; 2011 Dec; 20(24):4831-9. PubMed ID: 21920941
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of SNP array karyotyping on the diagnosis and the outcome of chronic myelomonocytic leukemia with low risk cytogenetic features or no metaphases.
    Palomo L; Xicoy B; Garcia O; Mallo M; Ademà V; Cabezón M; Arnan M; Pomares H; José Larrayoz M; José Calasanz M; Maciejewski JP; Huang D; Shih LY; Ogawa S; Cervera J; Such E; Coll R; Grau J; Solé F; Zamora L
    Am J Hematol; 2016 Feb; 91(2):185-92. PubMed ID: 26509444
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inferring loss-of-heterozygosity from unpaired tumors using high-density oligonucleotide SNP arrays.
    Beroukhim R; Lin M; Park Y; Hao K; Zhao X; Garraway LA; Fox EA; Hochberg EP; Mellinghoff IK; Hofer MD; Descazeaud A; Rubin MA; Meyerson M; Wong WH; Sellers WR; Li C
    PLoS Comput Biol; 2006 May; 2(5):e41. PubMed ID: 16699594
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genome-wide analysis of neuroblastomas using high-density single nucleotide polymorphism arrays.
    George RE; Attiyeh EF; Li S; Moreau LA; Neuberg D; Li C; Fox EA; Meyerson M; Diller L; Fortina P; Look AT; Maris JM
    PLoS One; 2007 Feb; 2(2):e255. PubMed ID: 17327916
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A new method to detect loss of heterozygosity using cohort heterozygosity comparisons.
    Green MR; Jardine P; Wood P; Wellwood J; Lea RA; Marlton P; Griffiths LR
    BMC Cancer; 2010 May; 10():195. PubMed ID: 20462409
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 250K single nucleotide polymorphism array karyotyping identifies acquired uniparental disomy and homozygous mutations, including novel missense substitutions of c-Cbl, in myeloid malignancies.
    Dunbar AJ; Gondek LP; O'Keefe CL; Makishima H; Rataul MS; Szpurka H; Sekeres MA; Wang XF; McDevitt MA; Maciejewski JP
    Cancer Res; 2008 Dec; 68(24):10349-57. PubMed ID: 19074904
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence and prognostic impact of allelic imbalances associated with leukemic transformation of Philadelphia chromosome-negative myeloproliferative neoplasms.
    Thoennissen NH; Krug UO; Lee DH; Kawamata N; Iwanski GB; Lasho T; Weiss T; Nowak D; Koren-Michowitz M; Kato M; Sanada M; Shih LY; Nagler A; Raynaud SD; Müller-Tidow C; Mesa R; Haferlach T; Gilliland DG; Tefferi A; Ogawa S; Koeffler HP
    Blood; 2010 Apr; 115(14):2882-90. PubMed ID: 20068225
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.